Back to Results

Acme United Corporation (ACU)

Featured in Overvalued Stocks

Acme United Corporation is a common stock listing on the NYSE representing an operating company focused on cutting, measuring, first aid, and sharpening products. The company serves school, home, office, hardware, sporting goods, and industrial customers across the United States, Canada, Europe, and other international markets. Its brands include Westcott for scissors, rulers, sharpeners, paper trimmers, cutters, glue guns, and related craft items; Clauss for cutting tools; DMT for sharpening products; and First Aid Only, PhysiciansCare, Spill Magic, First Aid Central, Safety Made, Med-Nap, Pac-Kit, and My Medic for first aid, safety, and cleaning products. Acme United sells through independent representatives, wholesale and retail distribution channels, and its own websites. The company was founded in 1867, was formerly known as Acme Shear Company, and is based in Shelton, Connecticut.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-ACU
$40.29
-14.5% Downside
Fair
$53
12.4% Upside
Fair
Good
July 2, 2026
July 23, 2026
0.64
1.4%
July 23, 2026
18.8x
1.5x
0.9x
179.1 M
224.3 M
21.6%
78.7%
4.6
25.1%
85.6%
Send a message
Valuation • Fair Value

Acme United Corporation (NYSE-ACU) Fair Value by Valuation Model

Compare the primary fair value estimate for Acme United Corporation (NYSE-ACU) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$40.29

Estimated downside of 14.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$35.77

Discounted cash flow valuation reference.

Ben Graham Formula Value

$27.71

Classic Ben Graham valuation formula reference.

DDM Fair Value

$20.33

Dividend discount model valuation reference.

EPV Fair Value

$47.72

Earnings power value estimate.

Comps Fair Value

$45.40

Comparable-company valuation reference.

Analyst Price Target

$53

Analysts imply upside of 12.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Acme United Corporation (NYSE-ACU) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Acme United Corporation (NYSE-ACU)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

202.9 M

Current operating scale indicator.

Revenue Forecast

215 M

Forward revenue estimate.

EBITDA

20.861 M

Current operating profitability reference.

EBITDA Forecast

18 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Acme United Corporation (NYSE-ACU) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Acme United Corporation (NYSE-ACU)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.57

No elevated caution signal from this screen.

Altman Z-Score

4.6

Relatively strong balance-sheet zone.

FCF / Net Income

85.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Acme United Corporation (NYSE-ACU). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Acme United Corporation (NYSE-ACU)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 23, 2026

Days to Earnings

2

Dividend Payment Date

July 23, 2026

Ex-Dividend Date

July 2, 2026

Dividend Yield

1.4%

Income yield reference.

Upcoming Dividend

0.64

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

25.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Acme United Corporation (NYSE-ACU), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Acme United Corporation (NYSE-ACU) Stock Forecast & Technical Outlook

Review Acme United Corporation (NYSE-ACU) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Acme United Corporation (NYSE-ACU) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Acme United Corporation (NYSE-ACU) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Acme United Corporation (NYSE-ACU) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Acme United Corporation (NYSE-ACU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Acme United Corporation (NYSE-ACU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Acme United Corporation (NYSE-ACU)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Acme United Corporation (NYSE-ACU) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

Acme United Corporation (NYSE-ACU) Stock FAQ

Quick answers about Acme United Corporation (NYSE-ACU) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$40.29
Estimated downside 14.5%
Valuation Rating
Overvalued
Estimated downside of 14.5%
Analyst Target
$53
Implied upside 12.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for Acme United Corporation (NYSE-ACU) is $40.29. This implies an estimated downside of 14.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 14.5% versus the current market price.

The available analyst price target for Acme United Corporation (NYSE-ACU) is $53. The analyst target implies estimated upside of 12.4%.

The current financial health read for Acme United Corporation (NYSE-ACU) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Acme United Corporation (NYSE-ACU) is July 23, 2026.

Based on the current data, dividend yield is 1.4%, upcoming dividend amount is 0.64, ex-dividend date is July 2, 2026, payment date is July 23, 2026.

The current P/E ratio listed for Acme United Corporation (NYSE-ACU) is 18.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Acme United Corporation is 179.1 M.

The current enterprise value listed for Acme United Corporation is 224.3 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Acme United Corporation is NYSE-ACU, and the stock is listed on NYSE.

Acme United Corporation (NYSE-ACU) is listed on NYSE.

The current debt-to-total-capital ratio listed for Acme United Corporation is 21.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Acme United Corporation is 78.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks on NYSE View more

Abbott Laboratories (ABT) Abbott Laboratories (ABT)
Stryker Corporation (SYK) Stryker Corporation (SYK)
Medtronic PLC (MDT) Medtronic PLC (MDT)
Boston Scientific Corp (BSX) Boston Scientific Corp (BSX)
Edwards Lifesciences Corp (EW) Edwards Lifesciences Corp (EW)
Becton Dickinson and Co (BDX) Becton Dickinson and Co (BDX)
Alcon AG (ALC) Alcon AG (ALC)
ResMed Inc (RMD) ResMed Inc (RMD)
Koninklijke Philips NV ADR (PHG) Koninklijke Philips NV ADR (PHG)
STERIS plc (STE) STERIS plc (STE)
Zimmer Biomet Holdings Inc (ZBH) Zimmer Biomet Holdings Inc (ZBH)
Solventum Corp (SOLV) Solventum Corp (SOLV)
Smith & Nephew SNATS Inc (SNN) Smith & Nephew SNATS Inc (SNN)
Penumbra Inc (PEN) Penumbra Inc (PEN)
Baxter International Inc (BAX) Baxter International Inc (BAX)
Globus Medical (GMED) Globus Medical (GMED)
Glaukos Corp (GKOS) Glaukos Corp (GKOS)
Teleflex Incorporated (TFX) Teleflex Incorporated (TFX)
Bausch + Lomb Corp (BLCO) Bausch + Lomb Corp (BLCO)
Envista Holdings Corp (NVST) Envista Holdings Corp (NVST)
Haemonetics Corporation (HAE) Haemonetics Corporation (HAE)
Integer Holdings Corp (ITGR) Integer Holdings Corp (ITGR)
Butterfly Network, Inc (BFLY) Butterfly Network, Inc (BFLY)
Enovis Corp (ENOV) Enovis Corp (ENOV)